maryland oncology hematology | Maryland Oncology Hematology maryland oncology hematology – Maryland Oncology Hematology

Maryland Oncology Hematology Adds Experienced Gynecologic Surgical Oncologist James Barter, MD, FACOG to White Oak Cancer Center

Dr. Barter is an accomplished surgeon and clinical researcher who will provide state-of-the-art treatments and minimally invasive surgical options to patients in the region.

Maryland, 3/15.2022 – Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has added Dr. James Barter, MD, FACOG to their gynecologic oncology and surgical team at White Oak Cancer Center. Dr. Barter is experienced in minimally invasive surgeries and has performed more than 1,700 robotic surgeries and procedures.

Dr. Barter joins Maryland Oncology Hematology at The White Oak Cancer Center. Dr. Barters’ current interests include surgery using the Da Vincia surgical robot to assist in gynecologic surgery. He is ranked in the top 15 users worldwide for robotic gynecologic and gynecologic oncology procedures and has lectured both locally and internationally on the topic. Along with his extensive research with Dr. David Min and the HCSS research division, Dr. Barter has activated and overseen clinical trials with over 1,300 patients entered in protocols since 2006.

“I’m looking forward to partnering with Maryland Oncology Hematology to provide leading-edge, researchbased, and patient-centered care to the community,” said Dr. Barter, a gynecologic surgeon at White Oak Cancer Center. “With a firm understanding of the latest treatment advances and surgical techniques, I hope to bring patients new cancer care options.”

Dr. Barter is recognized as one of the country’s leading gynecologists by Good Housekeeping, perennially as one of the Top Doctors in the Washington, D.C. area, as well as one of only two gynecologic oncologists noted as top doctors in Northern Virginia. He is currently a clinical professor at George Washington University and director of gynecologic oncology research at Holy Cross Hospital. He received his medical degree from the University of Virginia and completed two years of internal medicine and four years of obstetrics and gynecology at Duke University Medical Center, followed by a fellowship in gynecologic oncology at the University of Alabama Medical Center. He was at Lombardi Cancer Center/ Georgetown University Medical Center for 16 years, rising to the rank of professor.

His four-year interest in the development of a serum blood test for ovarian cancer detection will soon culminate in published research involving serum proteomics. In conjunction with Holy Cross, Dr. Barter continues his interest in protocols dealing with novel approaches for ovarian cancer treatment, having received research grants.

“We’re thrilled to have Dr. Barter join our team of talented surgeons at Maryland Oncology Hematology” said Kashif Firozvi, MD, Director at White Oak Cancer Center. “His background in research and clinical trials, as well as his impressive experience in both gynecologic oncology and surgery will be of great benefits to the local community.”

White Oak Cancer Center is located at 11886 Healing Way Suite 101, Silver Spring, MD, 20904. To learn more or to schedule an appointment, visit or call 301.343.3892.

About Maryland Oncology Hematology

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit

About US Oncology Network

Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,400 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.


To be distributed to local media:

Practice: Maryland Oncology Hematology

Contact: Mark Lamplugh

Phone : 561-762-9729

Email :


Men: Are You at Risk For Prostate Cancer?

Every man and those who love him should know how to prevent prostate cancer. This is because a man is diagnosed with prostate cancer every three minutes. Fortunately, thanks to strides in cancer research and cancer clinical trials, this disease is often preventable and has a very high survival rate, if detected in the early stages.

Who is at a higher risk of getting prostate cancer?

Some men have a higher risk of developing prostate cancer, but that doesn’t seem that they will develop the disease. Also, it is possible that a man with several risk factors will never develop the disease.

These risk factors include:

  • Age

The chances of developing prostate cancer drastically increase when a man turns 50. However, over half the cancer cases are discovered in men who are 65 or older. It is rare for a male under the age of 40 to develop prostate cancer; however, it can happen.

  • Genetics and Family History

Most prostate cancer occur in men without a family history, but there are some links that suggest their are inherited factors in developing prostate cancer. Discuss your family medical history with your doctor to help determine if you should have a genetic cancer risk assessment. If you have a family history of prostate cancer or many of the risk factors be sure talk to your doctor about things you can do to lower your risks.

  • Geographic Location

North Americans have a slightly higher risk than men in many other parts of the world. The reasons for this are still unknown, but are believed to be related to the more advanced screening methods in the United States.

  • Race

Race is another factor; your chances of dying from prostate cancer are over two times higher if you are a Caribbean man of African descent or African-American male. Studies indicate that this is because a high majority of African-American males have one or two copies of a genetic variant, which is a variation in the DNA sequence of their genomes. Also making them more than two-times more likely to die from the disease than white men.

It is best to be aware of risk factors and seek help with your doctor if you notice any abnormal changes.

How do you lower your risk of prostate cancer?

The success in treating prostate cancer has also provided more knowledge on how to lower our risks of prostate cancer. While there are many factors, such as genes, age and race, that we aren’t able to control; there are a few factors that we can control to help lower risks, including:

  • Schedule a physical with your doctor each year. This is important because the beginning stages of prostate cancer have few or no symptoms. An annual physical can help detect the disease in the earliest stages.
  • Eating a healthy diet that includes at least 2.5 cups of fruits and vegetables each day. Vegetables such as cabbage, broccoli, tomatoes, and cauliflower are especially good.
  • Avoiding obesity by keeping your body at a healthy weight.
  • Exercising on a regular basis.
  • Avoid smoking, or quit if you already smoke.
  • Talk to your doctor. If you feel that you are at a greater risk to develop prostate cancer, talk to your doctor about additional vitamins, mineral, or medications that you can take to help lower your risks.

Talk to your healthcare provider about what’s best for you and to schedule your yearly prostate cancer screening. However, increased urination or a weaker flow of urine can be signs of advanced prostate cancer, and while these problems can also be caused by other problems that have nothing to do with cancer, we recommend making an appointment to see your doctor about these symptoms. There are tests can detect prostate cancer in its earliest stages, whether or not you have any symptoms. If the test result is abnormal, it doesn’t necessarily mean that you have the disease. Your doctor will conduct other tests to find out for sure.

For help with this disease in the Maryland and Washington, D.C., area, contact us to make an appointment with one of our prostate cancer specialists. Our staff members are up-to-date on the latest clinical trials and cancer research and will help you choose the best treatment option to successfully battle this disease.



4 Questions to Ask Before Joining a Cancer Research Trial

Have you wondered whether there might be a new or different cancer treatment option available to you through cancer research trials? Or maybe your doctor has talked to you about the possibility of participating in a clinical trial for your cancer treatment. (Read more to understand “What is a Clinical Trial?”) Here are four things that patients and family members should feel free to ask their oncologist and research team before agreeing to participate.

Continue reading “4 Questions to Ask Before Joining a Cancer Research Trial”


Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology